[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368890-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368890-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","microplastics-as-emerging-carcinogens-from-environmental-pollutants-to-oncogenic-drivers","Microplastics as emerging carcinogens - from environmental pollutants to oncogenic drivers","","The review examines how microplastics (MPs) and nanoplastics (NPs) contribute etiologically to carcinogenesis and connects environmental contamination to cancer onset through bioaccumulation. Systematic screening of relevant studies followed PRISMA 2020 to ensure methodological transparency and quality. It highlights diverse MP accumulation across multiple human cancer tissues and describes mechanisms including chronic inflammation, oxidative stress, genotoxicity, altered lipid metabolism, immune microenvironment disruption, and oncogenic signaling pathway changes (NF-κB, PI3K/Akt/mTOR, Wnt/β-catenin, p53). It also covers evidence from in vitro, in vivo, and patient-derived contexts, plus detection in blood, placenta, and tumors, and outlines biomarker, patient-focused, and therapeutic targeting priorities.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/microplastics-as-emerging-carcinogens-from-environmental-pollutants-to-oncogenic-drivers/368890/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/microplastics-as-emerging-carcinogens-from-environmental-pollutants-to-oncogenic-drivers/368890.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What evidence links microplastics/nanoplastics to cancer development?","Question",{"text":63,"@type":64},"The review reports increasing evidence that MPs/NPs bioaccumulate and are associated with cancer onset, supported by in vitro, in vivo, and patient-derived findings.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which mechanisms do MPs/NPs use to promote carcinogenesis?",{"text":68,"@type":64},"MPs/NPs can trigger chronic inflammation, oxidative stress, genotoxicity, disturb lipid metabolism, alter the tumor immunological microenvironment, and disrupt key oncogenic pathways such as NF-κB, PI3K/Akt/mTOR, Wnt/β-catenin, and p53.",{"name":70,"@type":61,"acceptedAnswer":71},"Where have microplastics been detected in human biological matrices?",{"text":72,"@type":64},"The review highlights detection of MPs in blood, placenta, and tumor tissues, indicating direct human exposure and potential systemic effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368890,1790523103,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Mishra et al. Molecular Cancer (2025) 24:248 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02409-4](https://doi.org/10.1186/s12943-025-02409-4)  \nREVIEW Open Access  \nMicroplastics as emerging carcinogens:  from environmental pollutants to oncogenicdrivers  \nSarvesh Kumar Mishra 1†, Tapojyoti Sanyal2†, Pritha Kundu3, Rupesh Kumar4,5, Dipanjan Ghosh6, Gopal Chakrabarti6, Nilabja Sikdar7,8*, Sayan Bhattacharya9*, Santanu Paul 1* and Amlan Das 10*†  \nAbstract  \nThe widespread environmental pollution of microplastics (MPs) and nanoplastics (NPs) has become a major public health issue, with increasing evidence associating their bioaccumulation with cancer onset. This review offers a thorough examination of the etiological contributions of MPs/NPs in carcinogenesis, clarifying their mechanistic roles in in vitro, in vivo, and patient-derived evidences. Relevant studies were systematically identified and screened following the PRISMA 2020 guidelines to ensure methodological transparency and quality. We highlighted recent discoveries that emphasize the varied accumulation of MPs in several human cancer tissues, including lung, colorectal, gastric, cervical, breast, pancreatic, prostate and penile malignancies. These particles induce harmful biological effects by chronic inflammation, oxidative stress, genotoxicity, disturbance of lipid metabolism, and alteration of the tumor immunological microenvironment. Significantly, MPs/NPs disrupt various oncogenic signaling pathways, particularly NF-κB, PI3K/Akt/mTOR, Wnt/β-catenin, and p53, therefore facilitating tumor initiation, development, and metastasis. In vitro and in vivo studies have corroborated the carcinogenic potential of MPs/NPs, illustrating their capacity to cause cellular transformation, augment metastatic characteristics, and modify drug resistance pathways in cancer cells. Furthermore, the detection of MPs in human biological matrices, including blood, placenta, and tumor tissues, highlights direct human exposure and potential systemic effects. This review emphasizes the mechanistic insights with therapeutic significance, addressing current knowledge gaps in the field. Future research must prioritize biomarker identification, patient-centered investigations, therapeutic targeting, and the formulation of regulatory policies to alleviate the health hazards linked to microplastic exposure. Understanding  \n†Amlan Das, Sarvesh Kumar Mishra and Tapojyoti Sanyal are equal contributors.  \n*Correspondence: Nilabja Sikdar [snilabja@isical.ac.in](snilabja@isical.ac.in)  \nSayan Bhattacharya [sbhattacharya@nalandauniv.edu.in](sbhattacharya@nalandauniv.edu.in)[ ](sbhattacharya@nalandauniv.edu.in)Santanu Paul [santanupaul@iisertirupati.ac.in](santanupaul@iisertirupati.ac.in)[ ](santanupaul@iisertirupati.ac.in)Amlan Das  \n[adas5@rgu.ac](adas5@rgu.ac)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0","cbCait8xvWUa0Yj4","https://ap.wps.com/l/cbCait8xvWUa0Yj4","pdf",3571313,34,"English","# Abstract\n# Introduction\n## Background on microplastics: environmental pollutants with severe health impacts","[{\"question\":\"What evidence links microplastics/nanoplastics to cancer development?\",\"answer\":\"The review reports increasing evidence that MPs/NPs bioaccumulate and are associated with cancer onset, supported by in vitro, in vivo, and patient-derived findings.\"},{\"question\":\"Which mechanisms do MPs/NPs use to promote carcinogenesis?\",\"answer\":\"MPs/NPs can trigger chronic inflammation, oxidative stress, genotoxicity, disturb lipid metabolism, alter the tumor immunological microenvironment, and disrupt key oncogenic pathways such as NF-κB, PI3K/Akt/mTOR, Wnt/β-catenin, and p53.\"},{\"question\":\"Where have microplastics been detected in human biological matrices?\",\"answer\":\"The review highlights detection of MPs in blood, placenta, and tumor tissues, indicating direct human exposure and potential systemic effects.\"}]","Microplastics as emerging carcinogens - from environmental pollutants to oncogenic drivers | PDF",1790179112,86,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abc5723d5483c3c99fd5a0f51e24bfdd.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92f809c68ee03d3f71fb01c45223ca2a.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64c3ca93ca2f0c4c629a3aeb305d22ae.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c70fd440ca1bd40bad928f2241bfc5e.webp",980,1306]